Adial Pharmaceuticals, Inc. (ADIL)
ADIL Stock Price Chart
Explore Adial Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ADIL price movements and trends.
ADIL Company Profile
Discover essential business fundamentals and corporate details for Adial Pharmaceuticals, Inc. (ADIL) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
27 Jul 2018
Employees
5.00
Website
https://www.adialpharma.comCEO
Cary John Claiborne
Description
Adial Pharmaceuticals, Inc. is a biopharmaceutical enterprise operating at the clinical stage, dedicated to researching and developing innovative therapeutic options for the management and prevention of addiction and associated disorders. Its primary investigational compound, AD04, functions as a selective serotonin-3 antagonist and is currently undergoing pivotal Phase III clinical trials for the treatment of alcohol use disorder. Beyond this flagship product, the company is also exploring drug candidates aimed at providing non-opioid pain relief and addressing a range of other medical conditions. Established in 2010, Adial Pharmaceuticals, Inc. is headquartered in Charlottesville, Virginia.
ADIL Financial Timeline
Browse a chronological timeline of Adial Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$1.02.
Earnings released on 8 May 2026
EPS came in at -$1.48 surpassing the estimated -$2.73 by +45.79%.
Earnings released on 10 Mar 2026
EPS came in at -$1.81 surpassing the estimated -$2.10 by +13.81%.
Stock split effective on 6 Feb 2026
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 Nov 2025
EPS came in at -$2.00 surpassing the estimated -$2.25 by +11.11%.
Earnings released on 13 Aug 2025
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%.
Earnings released on 14 May 2025
EPS came in at -$0.34 surpassing the estimated -$0.50 by +32.00%.
Earnings released on 4 Mar 2025
EPS came in at -$0.15 surpassing the estimated -$0.38 by +60.53%.
Earnings released on 13 Nov 2024
EPS came in at -$0.38 surpassing the estimated -$0.50 by +24.00%.
Earnings released on 13 Aug 2024
EPS came in at -$0.59 falling short of the estimated -$0.39 by -51.28%.
Earnings released on 14 May 2024
EPS came in at -$0.68 falling short of the estimated -$0.51 by -33.33%.
Earnings released on 4 Apr 2024
EPS came in at -$1.35 falling short of the estimated -$0.76 by -77.63%.
Earnings released on 14 Nov 2023
EPS came in at -$1.14 matching the estimated -$1.14.
Earnings released on 21 Aug 2023
EPS came in at -$1.33 surpassing the estimated -$1.50 by +11.33%.
Stock split effective on 7 Aug 2023
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2023
EPS came in at -$2.75 surpassing the estimated -$3.50 by +21.43%.
Earnings released on 30 Mar 2023
EPS came in at -$2.75 surpassing the estimated -$3.75 by +26.67%.
Earnings released on 14 Nov 2022
EPS came in at -$3.00 surpassing the estimated -$4.50 by +33.33%.
Earnings released on 16 Aug 2022
EPS came in at -$4.00 matching the estimated -$4.00.
Earnings released on 16 May 2022
EPS came in at -$3.25 surpassing the estimated -$4.25 by +23.53%.
Earnings released on 28 Mar 2022
EPS came in at -$7.00 falling short of the estimated -$0.21 by -3.23k%.
Earnings released on 15 Nov 2021
EPS came in at -$5.50 matching the estimated -$5.50.
Earnings released on 12 Aug 2021
EPS came in at -$6.25 falling short of the estimated -$0.20 by -3.02k%.
ADIL Stock Performance
Access detailed ADIL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
